Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent
Marine Drugs · 2024
DOI: 10.3390/md22120577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Navindu Dinara Gajanayaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jeju Bio Research Center, Korea Institute of Ocean Science and Technology (KIOST), Jeju-si 63349, Republic of Korea. Hauptthemen laut MEDLINE: Polysaccharide-Lyases, Pseudoalteromonas, Hypoglycemic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Ocean Science and Technology.
Abstract (Originalsprache)
Green algae, particularly Ulva species, are rich in complex polysaccharides, such as ulvan, which have significant potential for biotechnological applications. However, the biochemical properties of ulvan depolymerised products remain underexplored. The enzymatic depolymerisation of ulvan has garnered attention owing to its cost advantages over alternative methods. Nevertheless, the biochemical characterisation of ulvan lyases, specifically those belonging to the polysaccharide lyase family 25 (PL25), is limited. In this study, we identified and biochemically characterised a novel PL25 ulvan lyase, PaUL25, which functions optimally at pH 10. Additionally, we explored the alpha (α)-glucosidase inhibitory properties of ulvan depolymerised products. PaUL25 exhibited optimum activity at 35 °C in Tris-HCl buffer (pH 10). Moreover, enzyme activity was enhanced by more than 150% in the presence of Mn2+ metal ions at and below concentrations of 10 mM. The endolytic action of PaUL25 produced ulvan oligosaccharides with degrees of polymerisation of 2 and 4 as its end products. Partially and completely hydrolysed ulvan oligosaccharides exhibited α-glucosidase inhibitory activity, with half inhibitory concentration IC50 values of 3.21 ± 0.13 and 2.51 ± 0.19 mg/mL, respectively. These findings expand our understanding of PL25 and highlight the pharmaceutical potential of ulvan oligosaccharides, particularly as antidiabetic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jeju Bio Research Center, Korea Institute of Ocean Science and Technology (KIOST), Jeju-si 63349, Republic of Korea.
- Department of Marine Technology & Convergence Engineering, KIOST School, University of Science and Technology, Daejeon 34113, Republic of Korea.
- Marine Natural Products Chemistry Laboratory, Korea Institute of Ocean Science and Technology (KIOST), Busan 49111, Republic of Korea.
ORCID-Profile: Chinmayee Bawkar, Yeon-Ju Lee, Gun-Hoo Park, Chulhong Oh, Youngdeuk Lee
Förderung
- Korea Institute of Ocean Science and Technology
Zitieren
APA
Gajanayaka, N. D., Jo, E., Bandara, M. S., Marasinghe, S. D., Bawkar, C., Lee, Y. J., Park, G. H., Oh, C., & Lee, Y. (2024). Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent. Marine Drugs. https://doi.org/10.3390/md22120577
Vancouver
Gajanayaka ND, Jo E, Bandara MS, Marasinghe SD, Bawkar C, Lee YJ, et al. Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent. Marine Drugs. 2024. doi:10.3390/md22120577
BibTeX
@article{Gajanayaka2024,
author = {Gajanayaka, Navindu Dinara and Jo, Eunyoung and Bandara, Minthari Sakethanika and Marasinghe, Svini Dileepa and Bawkar, Chinmayee and Lee, Yeon-Ju and Park, Gun-Hoo and Oh, Chulhong and Lee, Youngdeuk},
title = {Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22120577}
}
EUVIMED